Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial.
J Clin Exp Hepatol
; 12(2): 336-342, 2022.
Article
em En
| MEDLINE
| ID: mdl-35535057
ACLF, Acute on chronic liver failure; AKI, Acute Kidney Injury; CONSORT, Consolidated Standards of Reporting Trials; CTP, Child-Turcotte-Pugh; HE, Hepatic encephalopathy; HRS, Hepatorenal syndrome; MELD, Model of end-stage liver disease; SAAG, Serum ascites albumin gradient; SBP; SBP, Spontaneous bacterial peritonitis; UGIB, Upper Gastrointestinal Bleed; VH, Variceal hemorrhage; antibiotic; ascites; cirrhosis; hepatic encephalopathy; infection; primary; resistance; secondary; survival
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
Idioma:
En
Revista:
J Clin Exp Hepatol
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Índia